Dyslipidemia in veterans. Multiple risk factors may break the bank

D G Richlie1, S Winters, A V Prochazka

  • 1Division of Ambulatory Care, Denver (Colo) Veterans Affairs Medical Center 80220.

Insights

Veterans often have multiple cardiac risk factors, yet cholesterol screening and treatment in the Veterans Affairs system fall short of National Cholesterol Education Program guidelines. Aggressive screening and treatment are needed for dyslipidemias in this population.

Area of Science:

  • Cardiology
  • Public Health
  • Health Services Research

Background:

  • Veterans possess a higher prevalence of coronary heart disease risk factors, including smoking and male predominance.
  • Dyslipidemias require aggressive screening and treatment, particularly in veteran populations with multiple risk factors.

Purpose of the Study:

  • To evaluate cardiac risk factors and cholesterol screening practices among veterans.
  • To assess the impact of National Cholesterol Education Program (NCEP) guidelines on the Veterans Affairs (VA) healthcare system.
  • To determine the prevalence of dyslipidemias and adherence to NCEP guidelines in a veteran outpatient population.

Main Methods:

  • A retrospective review of 185 randomly selected outpatient charts at the Denver Veterans Affairs Medical Center.
  • Analysis of patient demographics, cardiac risk factors, cholesterol levels, and lipid analyses.
  • Extrapolation of findings to the larger VA healthcare system patient population.

Main Results:

  • The study population (n=185) was predominantly male (99.5%) with an average age of 58.3 years.
  • 60% of patients had cholesterol checked within 999 days; 84% had two or more cardiac risk factors.
  • 72% had cholesterol > 5.20 mmol/L, and 36.1% had cholesterol > 6.20 mmol/L. Only 16% of eligible patients received recommended lipoprotein analysis per NCEP guidelines.

Conclusions:

  • Current cholesterol screening and treatment practices within the VA system do not align with NCEP guidelines for veterans.
  • A significant number of veterans require further lipid evaluation and management for dyslipidemias.
  • Implementing NCEP guidelines necessitates substantial financial and personnel resources within the VA healthcare system.

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Lipids: Dietary Sources and Requirements01:18

Lipids: Dietary Sources and Requirements

Lipids are an essential component of a balanced human diet. Triglycerides, which make up the majority of dietary lipids, are found in both saturated fats—commonly present in meat, dairy products, and certain tropical plants like coconut, and hydrogenated oils such as margarine and baking shortenings (trans fats)—and unsaturated fats, which are abundant in seeds, nuts, olive oil, and most vegetable oils. The main sources of cholesterol include egg yolks, various meats and organ meats, shellfish,...
Overview of Lipid Metabolism01:24

Overview of Lipid Metabolism

Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...